These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8185703)
1. Is there an association between injectable collagen and polymyositis/dermatomyositis? Rosenberg MJ; Reichlin M Arthritis Rheum; 1994 May; 37(5):747-53. PubMed ID: 8185703 [TBL] [Abstract][Full Text] [Related]
2. Risk assessment of polymyositis/dermatomyositis after treatment with injectable bovine collagen implants. Hanke CW; Thomas JA; Lee WT; Jolivette DM; Rosenberg MJ J Am Acad Dermatol; 1996 Mar; 34(3):450-4. PubMed ID: 8609258 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and incidence of polymyositis and dermatomyositis in Japan. Ohta A; Nagai M; Nishina M; Tomimitsu H; Kohsaka H Mod Rheumatol; 2014 May; 24(3):477-80. PubMed ID: 24252012 [TBL] [Abstract][Full Text] [Related]
4. Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score. Lee CW; Muo CH; Liang JA; Sung FC; Hsu CY; Kao CH Endocrine; 2016 Apr; 52(1):86-92. PubMed ID: 26429781 [TBL] [Abstract][Full Text] [Related]
5. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study. Chung WS; Lin CL; Sung FC; Lu CC; Kao CH Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321 [TBL] [Abstract][Full Text] [Related]
6. Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis. Tomimitsu H; Ohta A; Nagai M; Nishina M; Ishihara S; Kohsaka H Mod Rheumatol; 2016; 26(3):398-402. PubMed ID: 26375202 [TBL] [Abstract][Full Text] [Related]
7. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Kuo CF; See LC; Yu KH; Chou IJ; Chang HC; Chiou MJ; Luo SF Br J Dermatol; 2011 Dec; 165(6):1273-9. PubMed ID: 21895620 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Dobloug C; Garen T; Bitter H; Stjärne J; Stenseth G; Grøvle L; Sem M; Gran JT; Molberg Ø Ann Rheum Dis; 2015 Aug; 74(8):1551-6. PubMed ID: 24695011 [TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis]. Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909 [TBL] [Abstract][Full Text] [Related]
11. Elevated cancer incidence in patients with dermatomyositis: a population based study. Airio A; Pukkala E; Isomäki H J Rheumatol; 1995 Jul; 22(7):1300-3. PubMed ID: 7562762 [TBL] [Abstract][Full Text] [Related]
12. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Sparsa A; Liozon E; Herrmann F; Ly K; Lebrun V; Soria P; Loustaud-Ratti V; Bouyssou-Gauthier ML; Boulinguez S; Bédane C; Jauberteau MO; Vidal E; Bonnetblanc JM Arch Dermatol; 2002 Jul; 138(7):885-90. PubMed ID: 12071815 [TBL] [Abstract][Full Text] [Related]
13. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Chow WH; Gridley G; Mellemkjaer L; McLaughlin JK; Olsen JH; Fraumeni JF Cancer Causes Control; 1995 Jan; 6(1):9-13. PubMed ID: 7718740 [TBL] [Abstract][Full Text] [Related]
14. Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires. Rosa J; Garrot LF; Navarta DA; Saucedo C; Scolnik M; Bedran Z; Garcia MV; Sabelli M; Catoggio LJ; Soriano ER J Clin Rheumatol; 2013 Sep; 19(6):303-7. PubMed ID: 23965482 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study. Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary involvement in polymyositis and in dermatomyositis. Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766 [TBL] [Abstract][Full Text] [Related]
17. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study. Wu C; Wang Q; He L; Yang E; Zeng X PLoS One; 2018; 13(2):e0192491. PubMed ID: 29474373 [TBL] [Abstract][Full Text] [Related]
18. Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Marie I; Ménard JF; Hachulla E; Chérin P; Benveniste O; Tiev K; Hatron PY Semin Arthritis Rheum; 2011 Aug; 41(1):48-60. PubMed ID: 21047670 [TBL] [Abstract][Full Text] [Related]
19. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Stockton D; Doherty VR; Brewster DH Br J Cancer; 2001 Jul; 85(1):41-5. PubMed ID: 11437400 [TBL] [Abstract][Full Text] [Related]